ACC
All Coverage
Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate
New results show benefits of Esperion’s cholesterol drug — but leave big questions unanswered
Tiny PhaseBio gets the New England Journal’s spotlight. Can its shares rebound?
Next for Apple Watch: a ‘pragmatic’ clinical trial with J&J to track heart health
Giant study shows Apple Watch can spot heart rhythm changes — but it’s far from ‘medical-grade technology’
Beware the hype over the Apple Watch heart app. The device could do more harm than good
